Emma Pooley, British Time Trial Championships 2009

Britain's Emma Pooley (Cervelo Test Team) won the GP Suisse time trial on Friday, continuing the excellent run of form that saw her win Belgian classic Fleche Wallonne less than two weeks ago.

Pooley scorched the 23.4km course - the same one used by the men's Tour de Romandie stage three time trial - beating Judith Arndt (HTC-Columbia) in second. French woman Jeannie Longo was third.

"I felt real bad this morning, kind of shaky and normally I am not too nervous before a time trial," Pooley said after the race.

"I thought I was still tired from training. After Fleche Wallonne I was training really hard for the Tour d'Aude that's coming so I thought maybe it wouldn't go so well today."

"But sometimes it's worth trying. I didn't really know how I was doing because I rode today without a power meter. Sometimes it's better to do it by feel... Overall I'm really pleased." 

Britain's Sharon Laws gave the Cervelo Test Team another top placing in fourth.

RESULTS

GP Suisse 2010: 23.4km time trial

1. Emma Pooley (GB) Cervelo Test Team in 35-33

2. Judith Arndt (Ger) HTC-Columbia at 34secs

3. Jeannie Longo (Fra) France at 45secs

4. Sharon Laws (GB) Cervelo Test Team at 1-13

5. Carla Ryan (Aus) Cervelo Test Team at 1-43

Related links

Pooley wins women's Fleche Wallonne

Thank you for reading 5 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Nigel Wynn

Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, n exceptional person to work with - his presence is sorely missed.